Table 2.
Gene Product | Location | Function | Human polymorphism phenotype | Mutant mouse TB phenotype | Ref. |
---|---|---|---|---|---|
TLR7 $ | Xp22 |
|
↑ HCV and HIV-1 | - | [97–99] |
TLR8 $ | Xp22 |
|
↑ TB susceptibility | - | [90,91] |
CYBB $ | Xp21 |
|
MSMD with CGD | Susceptible | [100,101] |
CD40L $ | Xq26 |
|
Together with TLR8 & IRAKI polymorphic variants, ↑ male-susceptibility to pulmonary TB | Similar to wild type but impaired granuloma formation | [102,103] |
IRAK1 $ | Xq28 |
|
Autoimmune diseases such as SLE, systemic sclerosis, rheumatoid arthritis, etc. | - | [104] |
CXorf21 $ | Xp21 |
|
Sexual dimorphism in SLE | - | [105] |
NEMO | Xq28 |
|
MSMD | - | [106] |
FOXP3 | Xp11 |
|
↑ female susceptibility to TB, ↑ viral susceptibility | - | [107,108] |
IL13RA1$ & RA2 | Xq24 |
|
Atopic disease | Unknown* | [109–112] |
CXCR3 $ | Xq13 |
|
Male-bias and pleuritis in SLE | Resistant to TB | [113,114] |
KDM6a $ | Xp11 |
|
Bladder cancer, B cell lymphoma | - | [115] |
miR-223 | Xq13 |
|
Rheumatoid arthritis | Susceptible to TB | [53,116–118] |
Respective genes are known to escape from XCI
Transgenic IL-13 overexpressing C57BL/6 mice show necrosis and ↑ TB susceptibility
Abbreviations: CGD, Chronic granulomatous disease; MSMD, Mendelian susceptibility to mycobacterial disease; HCV, Hepatitis C virus; HIV-1, Human immunodeficiency virus −1; TLR, Toll like receptors; CYBB, Cytochrome B-245 Beta Chain; CD40L: CD40 ligand; IRAK1, Interleukin 1 receptor associated kinase 1; miR, MicroRNA PMN, Polymorphonuclear neutrophils, NEMO, Nuclear factor-κB (NF-κB) essential modulator; FOXP3, Forkhead box P3; IL13RA1 & RA2, Interleukin 13 receptor subunit alpha 1 and alpha 2; CXorf21, chromosome X open reading frame 21; SLC15A4, solute carrier family 15 member 4; SLE, Systemic Lupus Erythematosus. Upward arrow: increase; ss, single strand